This is nothing new. Do you really believe a few hundred

New Post Public Reply Private Reply Replies (1) Message Board
hoops Alyosha #75835
485
This is nothing new. Do you really believe a few hundred posters on a message board are going to counter a somewhat organized short attack on an OTC stock? A falling share price is a self-fulfilling prophecy. The companies have been sanctioned by the SEC time and again. Cytodyn doesn't have the time or the money to defend itself and either do we.

I'm not complaining about the posts. The concerns are legitimate. However, no short attack is going to overwhelm an FDA approval of the first therapeutic against COVID. No short attack is going to overwhelm approval of a simple, therapeutic against HIV. No short attack is going to overwhelm a real solution to deadly, triple-negative breast cancer.

To gain perspective we have to look down the road, just as if you are driving a car. If you look at the hood ornament (day to day activity), you will become disoriented. People have take Vyrologix and are alive or acquired a much improved quality of life because of it. To quote Dr. Patterson:

"An anecdote doesn't come off life support." This is the real battle. Getting Vyrologix out to the masses and saving lives. The share price will follow if...

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

The Future of Pharmaceutical Contract Packaging: Growth Insights

Updated Category News Views 74

Overview of the Pharmaceutical Contract Packaging Market The global market for pharmaceutical contract packaging is set to experience notable growth, propelled by advances in technology and increased investment in research and development. Estimates indicate a remarkable increase of USD 9.32 billion from 2024 to 2028, equating to a compound annual growth rate (CAGR) of...

Continue Reading
Palantir's CTO Highlights US Deterrence Challenges Ahead

Updated Category News Views 209

Palantir's CTO Discusses National Security Challenges Shyam Sankar, the Chief Technology Officer of the innovative data analytics and cybersecurity company Palantir Technologies Inc. (NASDAQ: PLTR), recently expressed serious concerns regarding America's fading deterrence capacity. While appearing on the New York Times podcast, he made it clear that the nation is no...

Continue Reading
Concerns Rise for Long-Term Investors of Super Micro Computer

Updated Category News Views 211

Investigation Launch: A Call to Action for Shareholders Bragar Eagel & Squire, P.C., a highly regarded law firm focused on shareholder rights, is launching an investigation into potential claims against Super Micro Computer, Inc. (NASDAQ: SMCI). This examination primarily targets the company’s conduct leading up to a class action lawsuit filed against it. The firm is...

Continue Reading
Children’s Place Reports Significant Results and Strategies Ahead

Updated Category News Views 283

Strong Performance in the Fourth Quarter The Children’s Place, Inc. (Nasdaq: PLCE), recognized as North America's leading children's specialty retailer, has reported remarkable progress in its financial performance for the fourth quarter. The company achieved net sales totaling $409 million for this quarter, along with a total of $1.386 billion for the entire fiscal...

Continue Reading
The Incredible Growth of Extra Space Storage Over Time

Updated Category News Views 391

Understanding Extra Space Storage's Historical Returns Extra Space Storage (NYSE: EXR) has significantly outperformed the market during the past 15 years, registering an impressive annualized return of 16.14%. This performance is not just a statistic; it represents a compound growth that can transform an initial investment. The Power of Compound Returns To illustrate...

Continue Reading